Efficacy and Safety of Low-Dose Hypofractionated Radiotherapy Combined with Immunotherapy for Liver Metastases: A Single-Center Retrospective Analysis
OncoTargets and Therapy · 2026-10 · Volume 19 · 1-8
DOI: 10.2147/ott.s627124 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-10. Verfasst von Lanqun Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, People's Republic of…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology Department, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou, People's Republic of China.
- Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, People's Republic of China.
ORCID-Profile: Dongqing Li
Zitieren
APA
Qin, L., Wei, Y., Tao, L., Jiang, H., Qian, D., Geng, Q., & Li, D. (2026). Efficacy and Safety of Low-Dose Hypofractionated Radiotherapy Combined with Immunotherapy for Liver Metastases: A Single-Center Retrospective Analysis. OncoTargets and Therapy, Volume 19, 1-8. https://doi.org/10.2147/ott.s627124
Vancouver
Qin L, Wei Y, Tao L, Jiang H, Qian D, Geng Q, et al. Efficacy and Safety of Low-Dose Hypofractionated Radiotherapy Combined with Immunotherapy for Liver Metastases: A Single-Center Retrospective Analysis. OncoTargets and Therapy. 2026;Volume 19:1-8. doi:10.2147/ott.s627124
BibTeX
@article{Qin2026,
author = {Qin, Lanqun and Wei, Yanshuang and Tao, Li and Jiang, Hua and Qian, Danping and Geng, Qian and Li, Dongqing},
title = {Efficacy and Safety of Low-Dose Hypofractionated Radiotherapy Combined with Immunotherapy for Liver Metastases: A Single-Center Retrospective Analysis},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--8},
doi = {10.2147/ott.s627124}
}
EUVIMED